Dexmedetomidine exerts protective effects on liver transplantation form experimental study to clinical evaluation

Not Applicable

Completed

• Conditions: Liver transplant

• Registration Number: ChiCTR2400088867
• Lead Sponsor: The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

First, patients with end-stage liver disease due to various liver diseases were included, and the surgical methods were allogeneic orthotopic liver transplantation, aged between 16 and 65 years.

Exclusion Criteria

Patients with combined multi-organ transplantation, incomplete clinical records, and lost contact with follow-up were excluded.

Study & Design

• Study Type: Observational study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
survival rate;

Secondary Outcome Measures

Name	Time	Method
Liver function;